Alterations in genes such as RAB5B, SRPX2, and TIAM1, which are involved in synaptic trafficking and cytoskeletal regulation, could further exacerbate synaptic dysfunction in MDD [29]. This evidence concerns the gene SRPX2 and major depressive disorder.